Latest Breaking News On - American society of clinical psychopharmacology annual meeting - Page 1 : comparemela.com

Phase 2b Study Explores Efficacy of MM-120 for the Treatment of GAD

Experts shared the study results in a poster presentation at the 2024 ASCP Annual Meeting.

Post Hoc Analysis Explores Risk-Benefit Profile of KarXT

J&J's oral add-on aces phase 3 in major depressive disorder

J&J's oral drug improved depressive symptoms and sleep in a phase 3 trial for patients who previously did not benefit from antidepressants alone.

Efficacy of Semaglutide for the Treatment of Substance Use Disorders

An analysis presented at the ASCP Annual Meeting explored the safety and tolerability of the treatment for alcohol and tobacco use disorders.

Efficacy of Brexpiprazole and Sertraline for the Treatment of PTSD

A poster at the 2024 ASCP Annual Meeting shared data from 3 randomized clinical trials on the safety and tolerability of this treatment combination.